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The Mason-Pfizer monkey virus (M-PMV) Gag protein follows a morphogenesis pathway in which immature capsids are preassembled within
the cytoplasm before interaction with and budding through the plasma membrane. Intracytoplasmic assembly is facilitated by sequences within the
p12 domain of Gag that we have termed the Internal Scaffold Domain (ISD). If M-PMV utilizes an ISD then what provides the equivalent function
for most other retroviruses that assemble at the plasma membrane? To investigate the possibility that the membrane itself fulfills this role, we have
combined functional deletion of the ISD with a mutation that disrupts intracellular targeting or with a plasma membrane targeting signal. By either
modification, targeting of ISD-deleted Gag to the plasma membrane restores particle production. These results provide support for a model in
which the plasma membrane and the D-type ISD provide an interchangeable scaffold-like function in retrovirus assembly.
D 2005 Elsevier Inc. All rights reserved.Keywords: M-PMV; Retrovirus; Assembly; Gag; Immature capsid; Internal Scaffold Domain; Plasma membraneIntroduction
Retroviruses assemble in a complex process involving an
intermediate immature capsid that upon budding from the
plasma membrane undergoes a morphologically dramatic
maturation step to yield the infectious particle. This transfor-
mation is mediated by the viral proteinase, which cleaves
polyprotein precursors allowing the liberated components to
reassemble into the core structures of the mature virion. The
exception to this is the Spumaviruses, which undergo limited
proteolytic processing (reviewed in Swanstrom and Wills,
1997). Mature cores take different forms characteristic for each
retrovirus, such as cones, cylinders, or spheres for human
immunodeficiency virus (HIV), Mason-Pfizer monkey virus
(M-PMV), or murine leukemia virus, respectively (reviewed in
Vogt, 1997). The structure of the HIV core, in particular, has
been the subject of intensive scrutiny. Not only has the core of
budded particles been analyzed in detail by electron (Welker et
al., 2000) and cryo-electron microscopy (Benjamin et al., 2005;0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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assembly systems have been developed that imitate cone
formation by the assembly of tubes (Campbell and Vogt, 1995;
Ehrlich et al., 1992; Gross et al., 1997; Lanman et al., 2003)
and even morphologically authentic cones (Ganser et al.,
1999). Analysis by cryoelectron microscopy of these structures
produced in vitro has led to the development of a fullerene
model for the HIV core (Briggs et al., 2003; Li et al., 2000),
which by simple rearrangement of pentagonal elements, can be
modified to resemble the spheres and cylinders seen as the
cores of other retroviruses (Ganser-Pornillos et al., 2004).
Thus, despite gross morphological differences, the arrangement
of mature subunits in the mature virion is likely similar in most
retroviruses.
The immature virion among retroviruses is likewise similar
in both morphologic and biochemical characteristics. It is
composed primarily of polyprotein precursors and appears in
thin section electron microscopy as a particle composed of
concentric rings of varying density surrounding an electron
lucent center (reviewed in Vogt, 1997). These immature
particles, like their mature counterparts, can vary greatly in
mass and diameter, reflecting a variability in the number of
structural precursor molecules (Briggs et al., 2004b; Fuller et6) 317 – 327
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Simon, 1999; Wilk et al., 2001; Yeager et al., 1998). The
pleomorphic nature of immature retrovirus particles has made
traditional crystallographic atomic-level structural analysis
impossible. However, cryoelectron microscopy has revealed a
radial arrangement of densities within the primary structural
protein Gag (Briggs et al., 2004a, 2004b; Fuller et al., 1997;
Kingston et al., 2001; Parker et al., 2001; Wilk et al., 2001;
Yeager et al., 1998). The order of densities from exterior to
interior corresponds with the Gag domains in their N to C
terminal positions within the precursor protein: N-matrix (MA),
the two domains of capsid (CA), and nucleocapsid (NC) -C.
The correspondence of primary elements in immature particles
to the Gag polyprotein precursor is consistent with the widely
confirmed result that for most retroviruses Gag is the only viral
gene product necessary for such particles to assemble and bud
from the cell, with the exception being the Spumaviruses where
Env is required (reviewed in Swanstrom and Wills, 1997). The
recent systems using purified fragments of Gag (Campbell and
Vogt, 1997; Campbell et al., 2001; Gross et al., 1998, 2000;
von Schwedler et al., 1998; Yu et al., 2001) or Gag synthesized
in vitro (Sakalian et al., 1996, 2002) to form immature particle-
like structures have further confirmed Gag as the only essential
protein of the assembled immature particle.
Despite the structural similarity of immature particles, the
location of assembly differs by retrovirus genus. While the
majority assemble at a membrane, typically though not always
the plasma membrane (Ono and Freed, 2004; Pelchen-
Matthews et al., 2003), the Betaretroviruses assemble their
immature particles inside the cytoplasm without any apparent
membrane involvement. Historically, with the exception of the
Spumaviruses, retroviruses that assemble at the plasma
membrane were designated C-type while those that assemble
in the cytosol were designated as B- or D-type. Of the
Betaretroviruses (the B- and D-type viruses), the most
extensively studied with regard to its assembly and morpho-
genesis is the Mason-Pfizer monkey virus (M-PMV). An 18-
amino acid sequence within the MA domain of M-PMV Gag,
termed the cytoplasmic targeting/retention signal (CTRS)
(Choi et al., 1999; Rhee and Hunter, 1990a; Yasuda and
Hunter, 2000), directs nascent Gag polypeptides to a pericen-
triolar region of the cell where assembly of immature capsids
occurs (Sfakianos et al., 2003). These particles are then actively
transported (Weldon et al., 1998) by either an Env/Gag
interaction on recycling endosomes or by a less efficient and
as yet undescribed default pathway to the plasma membrane
where they bud (Sfakianos and Hunter, 2003). Thus, unlike
most retroviruses that assemble and simultaneously become
enveloped at the plasma membrane, the processes of assembly,
envelopment, and budding are spatially and temporally
separated for M-PMV.
Numerous mutants of M-PMV Gag have been described
that display altered transport, assembly, or both (Rhee and
Hunter, 1987, 1990a, 1991; Sommerfelt et al., 1992; Stansell
et al., 2004; Yasuda and Hunter, 2000). We have described the
use of an in vitro synthesis and assembly system based upon
coupled transcription and translation in a rabbit reticulocytelysate (Sakalian et al., 1996) to distinguish between defects in
intracellular transport and the process of assembly itself for
two gag gene mutants (Sakalian and Hunter, 1999). The
matrix domain mutant R55W redirects Gag to the plasma
membrane where assembly subsequently occurs and was the
first evidence for a CTRS in M-PMV Gag (Rhee and Hunter,
1990a). We have shown that R55W can assemble in both the
in vitro translation-assembly system and within inclusion
bodies in bacteria and thus has retained the capacity to
assemble in the cytoplasm. In contrast, deletions within the
p12 domain of M-PMV Gag appear to affect the efficiency of
particle formation such that under low-level expression
conditions Gag fails to assemble (Sommerfelt et al., 1992).
We have demonstrated that the efficiency of assembly in the
in vitro system mirrors that seen in cells under expression
conditions similar to that of an infection (Sakalian and Hunter,
1999). However, overexpression of Gag, either in bacteria
(Sakalian and Hunter, 1999), or in COS-1 cells or CV-1 cells
by the vaccinia/T7 system (Sommerfelt et al., 1992), can
compensate for the effect of the deletion and allow Gag to
assemble. These results argue that the p12 domain functions
as an ‘‘Internal Scaffold Domain’’ (ISD), much like the
scaffold proteins of numerous bacteriophage, which as an
aspect of their function increase the efficiency of particle
assembly, and plays a critical role in the membrane-inde-
pendent assembly of immature capsids. We have also shown
that fusing M-PMV p12 to HIV Gag enables the chimera to
efficiently assemble in the in vitro translation system (Saka-
lian et al., 2002).
The idea that an ISD serves to modulate the efficiency of
capsid assembly leads to the question of what performs this
function for retroviruses that do not contain it. After all, the
processes of assembly cannot be fundamentally different if it is
possible to convert a virus that assembles in the cytoplasm into
one that assembles at the plasma membrane by means of a
single amino acid substitution (Rhee and Hunter, 1990a;
Yasuda and Hunter, 2000). We hypothesized that for many
retroviruses the plasma membrane itself may provide the
scaffold-like function for assembly. To test this hypothesis, we
examined M-PMV Gag variants containing a deletion of ISD
function combined with a mutation to target Gag to the plasma
membrane. Consistent with the hypothesis that a membrane
can function to assist Gag assembly, we found that targeting
Gag to the plasma membrane restores particle production for
ISD-deleted Gag.
Results
The Internal Scaffold Domain deletion phenotype is dominant
in an in vitro assembly system
To test the hypothesis that the plasma membrane can
substitute for the ISD if Gag proteins are directed there, we
constructed a series of mutant M-PMV gag genes that contain
the R55W mutation, an ISD deletion (D1–25), or both (Fig. 1).
The combination of these two mutations (R55W/D1–25)
within the D-type Gag molecule would be expected to render
Fig. 1. Schematic illustration of M-PMV Gag variants. M100A contains a methionine to alanine change at amino acid 100 of Gag to prevent translation initiation at
this position. For purposes of this study, M100A represents the wild type. R55W contains an additional single amino acid change at position 55 that inactivates the
CTRS. The deletion in D1–25 removes a region critical to the functioning of the ISD. Gag68 was created by mutation of the first methionine codon to that for
alanine, thus forcing translation to initiate at the second methionine codon, number 100. The result is a Gag precursor precisely deleted of the MA domain. Versions
of Gag68 were created containing either the first 10 amino acids of src, so that the N-terminus is myristylated, or an altered version with glycine two changed to
alanine to prevent myristylation. Further derivatives of these were made by incorporating two ISD defective deletions, D1–25 and D8–58. Numbers at the top
indicate the starting residue within Gag for each domain as well as the last residue of the polyprotein.
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Examination of the morphogenesis of capsids assembled from
this Gag variant was then performed in vitro and in cells. We
also examined in parallel an M-PMV Gag species, Gag68,
deleted of its MA domain, and thus, devoid of the transport and
membrane binding elements of the precursor (Fig. 1). In
addition to the mutations under analysis in this study, all
constructs that include MA express the M100A substitution in
order to prevent initiation of translation at the second AUG in
the gag sequence. This was done to simplify the analysis by
reducing the number of Gag-related species produced in vitro
and in cells. The M100A substitution has no discernable effectupon virus replication in culture as has been discussed
previously (Sakalian and Hunter, 1999).
Before analyzing the dual mutant Gag in cells, it was
necessary to first ascertain its phenotype in the in vitro system.
We predicted that since there is no active cellular transport
mechanism available within the in vitro system, the D1–25
deletion would be dominant. This is indeed what we found;
Gag containing both R55W and D1–25 failed to assemble into
particulate material as examined by sucrose gradient analysis
(Fig. 2) and produced a profile of material in the gradient
similar to that produced by the single mutant, D1–25, species.
In contrast, the MA-deleted version, Gag68, produced partic-
Fig. 2. Comparison of in vitro-synthesized and -assembled Gag species by
sucrose gradient analysis. Aliquots of gradient fractions were electrophoresed
on an SDS-10% polyacrylamide gel. Lane numbers indicate gradient fractions
beginning with the top fraction at no. 1. Lanes L contain an equivalent aliquot
of the translation reactions before gradient fractionation. Lanes P contain
material remaining as a pellet in the tube after removal of the gradient. Lanes
6–9 contain material indicative of immature capsids at a density of ¨1.19–
1.21 g/ml. Pr78gag and Pr95gag – pro indicate the positions of the Gag and Gag–
Pro precursor polypeptides of M-PMV, respectively.
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the M100A control or R55W.
The CTRS mutation can compensate for the Internal Scaffold
Domain deletion for particle release
To examine the potential effect of transport on an ISD-
deleted Gag to the plasma membrane, we next tested
expression of the dual R55W/D1–25 mutant Gag in mam-
malian cells. If the plasma membrane functions as a scaffold
for the assembly of C-type viruses, then particle production ofthe ISD-deleted Gag should be restored by the CTRS
mutation. Stably transfected HeLa cell lines were created
using the pSHRM15 series of plasmids containing the various
species of gag (Fig. 1) in the context of a complete M-PMV
provirus.
Particle production was measured by pulse-chase analysis
of these cells (Fig. 3A). The single mutations, R55W and
D1–25, were tested in parallel with the dual mutant and
Gag68. For all constructs examined, three forms of Gag
precursor can be seen: Gag, Gag–Pro, and Gag–Pro–Pol.
These result from the slippage of the ribosome at two
frameshift signals between the gag and pro and also the pro
and pol reading frames (Jacks et al., 1987, 1988). The ability
of each proviral species to produce particles was monitored
by the release of matured CA (p27) protein into the tissue
culture supernatant (Fig. 3A, lower panel). Since the culture
medium was filtered and virus was collected by centrifuga-
tion, only assembled particles were examined, and not CA
released by secretion or cell lysis.
Both M100A (wild type) and the single R55W mutant
released the matured CA protein indicative of virus particle
production. Consistent with previously reported data, the single
D1–25 species failed to release a significant quantity of CA
protein (Sommerfelt et al., 1992). Likewise, Gag68 failed to
release virus particles. In contrast, the dual R55W/D1–25
species released a significant amount of particles, suggesting
that interaction with the plasma membrane can, indeed,
substitute for the loss of ISD function.
To measure the relative efficiency with which particles were
produced, the release of CA as a function of the expression of
Gag in cells was determined for each cell line and then
compared with that from cells expressing M100A (Fig. 3B).
The quantity of mature CA released by each cell line and the
amount of Gag synthesized during the pulse labeling was
counted. After correction for the number of methionines in
each species, the amount of particulate protein in the culture
medium was divided by the quantity in the cell to obtain a
proportion for particle released. This proportion for each cell
line was then divided by that for the line producing the M100A
(wild type) species to give a measure of relative release
[relative release = (CA/Gag)mutant / (CA/Gag)wild type, where
CA and Gag are the methionine corrected counts for CA in
released particles and pulse-labeled Gag, respectively]. The
CTRS mutant, R55W, is approximately twice as efficient in
particle release as wild type, while the ISD deletion, D1–25, is
nearly completely defective. The greater efficiency with which
R55W produces particles has been noted previously and has
been attributed to the more rapidly traversed C-type morpho-
genesis pathway versus the multi-step B/D-type pathway (Rhee
and Hunter, 1990a). In contrast to the single ISD deletion, the
double CTRS/ISD mutant released particles at about 60% of
wild type. The matrix-deleted species, Gag68, is completely
defective for particle production.
Failure to release particles by the D1–25 and Gag68
mutants might result from rapid degradation in the cytoplasm
rather than from defects in assembly or transport. Previous
analysis of R55W (Rhee and Hunter, 1990a; Yasuda and
Fig. 3. Pulse-chase analysis of particle production by stably transfected HeLa
cell lines expressing M-PMV gag species. Cells were labeled for 30 min with
[35S]-methionine and then chased overnight. (A, top panel) SDS-12% PAGE of
immunoprecipitations of lysed, pulse-labeled cells. (A, center panel) immuno-
precipitation of lysed cells after the chase. (A, bottom panel) immunoprecip-
itation of particles collected after the chase from the cell medium. Labels for
each expressed species are given at the top of the gel lanes. HeLa indicates the
parental cell line. Pr78gag, Pr95gag – pro, and Pr180gag – pro – pol indicate the
positions of the Gag, Gag–Pro, and Gag–Pro–Pol precursor polypeptides of
M-PMV, respectively. p27CA indicates the position of the proteolytically
matured capsid protein. The numbers to the left indicate the position of
prestained relative molecular size standards in kilodaltons. (B) Comparative
analysis of virus production by quantitation of CA released from cells in a
particle form. Each species is shown relative to the M100A variant, which
serves as the wild-type control, set to one. Results shown are the average of two
experiments with the range of values given by error bars. The Gag68 species
failed to produce any measurable CA released as particles.
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showed that these mutants are not significantly less stable than
wild-type Gag. To confirm that the various Gags were not
destabilized in our analysis, we examined the amount of cell
associated Gag remaining after the chase. For each species, the
remaining amount was roughly inversely proportional to its
relative particle release, with one exception (Fig. 3A, center
panel). Consistent with previous findings that deletions in MA
destabilize Gag (Rhee and Hunter, 1990b), only approximately
50% of Gag68 remained after the chase even though none was
released.
The dual CTRS/DISD mutant can assemble at the plasma
membrane
To gain a better understanding of the assembly pheno-
types of the CTRS and ISD mutations, HeLa cell lines
expressing these Gag species were analyzed by thin section
electron microscopy. Immature capsid structures were
readily identified in cells expressing the M100A M-PMV
Gag species (Fig. 4A) with large clusters frequently
observed (Fig. 4B). A few immature D-type capsid
structures were observed in HeLa cells expressing the
CTRS mutant R55W (not shown), but curiously no C-type
structures were observed. Previous investigations of this
mutant using COS or insect cell overexpression have
established its morphogenesis as predominantly C-type
(Parker and Hunter, 2000; Rhee and Hunter, 1990a). Our
inability to observe such structures compared to past reports
is likely due to a lower expression level from the M-PMV
promoter than is possible with the overexpression systems
used in previous studies. Consistent with the biochemical
data (Fig. 3B), for the ISD deletion D1–25, only a very
few preassembled immature particles were observed in the
cytoplasm compared to cells expressing M100A (not
shown). Significantly, for the CTRS/ISD double mutation/
deletion, several C-type structures were observed (Fig. 4C).
The matrix-deleted Gag68 protein also assembled efficiently
into immature-like particles. In fact, large clusters of
structures were seen (Fig. 4D).
Direct targeting to the plasma membrane rescues particle
production for ISD deletions
While the R55W mutation rescues particle production for
the ISD mutation using HeLa cells (Fig. 3), the results were
somewhat different when analyzed in human osteosarcoma
(HOS) cells. In these cells, the R55W substitution and the ISD
deletion each contributed to a reduction in particle release, with
C-type assembling structures observed in cells expressing both
D1–25 (Fig. 4E) and R55W/1–25 (Fig. 4F). The different
behavior of the mutations in another cell type is not surprising.
As was noted in the original description of the mutation, the
alteration of transport by R55W is not 100% efficient; some D-
type immature particles are still observed in the cytoplasm
(Rhee and Hunter, 1990a). Also, in a study of M-PMV particle
production from insect cells, wild-type and R55W versions of
Fig. 4. Representative fields from analysis of M-PMV Gag variants expressed in stably transfected cell lines and examined by thin-section electron microscopy. Solid
arrows indicate Gag species that have followed D-type morphogenesis to produce intracytoplasmic immature capsids. The open arrows indicate Gag assembling at
the plasma membrane via the C-type morphogenic pathway. (A and B) M100A (wild type) in HeLa cells. (C) R55W/D1–25 in HeLa cells. (D) Gag68 in HeLa cells
(E) D1–25 in HOS cells. (F) R55W/D1–25 in HOS cells. All fields are shown at 20,000 magnification save that in panel B, which is at 10,000.
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wild type was specifically impaired in High Five cells (Parker
and Hunter, 2000). While R55W could still bud from High
Five cells, it was less efficient than from Sf9 cells providing a
precedent for cell-type dependent differences in M-PMV
mutant particle morphogenesis. Moreover, the R55W mutation
inactivates the CTRS, but does not necessarily directly target
Gag to the plasma membrane. Whether Gag follows an
alternate pathway in the absence of CTRS function or just
finds its way to the plasma membrane by default is not yet
understood.
To direct the targeting of R55W in HOS cells, we
reconstructed our gag derivatives to contain the well-
characterized src plasma membrane targeting signal. The
first 10 codons of the src oncoprotein were inserted into the
Gag68 construct thus substituting the entire MA domain in
the expressed Gag protein. This short sequence of src is
sufficient to direct the myristylation of the nascent polypep-
tide and target the protein to the plasma membrane
(Deichaite et al., 1988; Resh, 1989; Resh and Ling, 1990).
Studies of Rous sarcoma virus (RSV) assembly in mamma-
lian cells were greatly facilitated by the appendage of this
same signal sequence to the N-terminus of RSV Gag (Wills
et al., 1989).For each variant of Gag analyzed, a myristylation plus
and a control myristylation minus version was constructed
(see Materials and methods). Stably transfected HOS cell
lines were created and pulse-chase analyses were used to
measure particle production (Fig. 5). In addition to the D1–
25 ISD deletion already described, a more extensive D8–58
deletion was also analyzed in parallel (Sommerfelt et al.,
1992). The M100A and Gag68 versions again served as
positive and minus controls for particle production. All the
cell lines expressed their respective proteins with both the
Gag and Gag–Pro precursors seen in the immunoprecipita-
tions of cell lysates (Fig. 5A). The culture medium from
these cells was filtered and virus was collected by
centrifugation such that only assembled particles were
examined, as before. Again, the ability of each proviral
species to produce particles was monitored by the release of
matured CA (p27) protein into the tissue culture supernatant.
As expected, the M100A cell line produced particles while
the Gag68 did not. Also as expected, all the cells expressing
the myristylation minus src versions of Gag failed to release
particles. In contrast, all the cells expressing the myristyla-
tion positive versions released a significant amount of
particles; although when quantitated, these amounts were
only about 20% of M100A (Fig. 5B). The presence or
Fig. 5. Pulse-chase analysis of particle production by stably transfected HOS
cell lines expressing M-PMV src-directed Gag proteins. Cells were labeled for
1 h with [35S]-methionine and then chased 8 h in complete DMEM. (A, top
panel) SDS-12% PAGE of immunoprecipitations of lysed, pulse-labeled cells.
(A, bottom panel) immunoprecipitation of particles collected after the chase
from the cell medium. Lanes for each expressed species are given at the top of
the gel. HOS indicates the parental cell line. The approximate positions of the
Gag and Gag–Pro precursor polypeptides are indicated. CA indicates the
position of the proteolytically matured capsid protein. (B) Comparative analysis
of virus production by quantitation of CA released from cells in a particle form.
Each species is shown relative to the M100A variant, which serves as the wild-
type control, set to one. Results shown are the average of two experiments with
the range of values given by error bars. The Gag68 species and all myristylation
minus versions (not shown) failed to produce measurable CA released as
particles.
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the efficiency of particle production.
Discussion
In previous reports, we have highlighted the role of an
internal domain within the M-PMV Gag precursor that
functions as a scaffold (ISD) to augment the ability of Gag
to multimerize into immature particles (Sakalian and Hunter,
1999; Sommerfelt et al., 1992). We have also further described
a domain in MA, termed the cytoplasmic targeting and
retention signal (CTRS), that has no effect upon assembly
itself (Sakalian and Hunter, 1999), but transports nascent Gag
precursors to the pericentriolar region for assembly (Sfakianoset al., 2003). Since a single amino acid substitution R55W can
largely disrupt the CTRS and transform the morphogenesis of
M-PMV from D-type to C-type, the underlying mechanism of
Gag assembly between C- and D-type retroviruses must be
fundamentally the same. Therefore, if D-type Gag precursors
require an ISD, what provides this function for C-type Gag?
We hypothesized that the plasma membrane may play this role
since numerous studies have pointed to the critical role
membrane interaction plays in the assembly of retroviruses
(Bryant and Ratner, 1990; Rein et al., 1986; Spearman et al.,
1994; Wills et al., 1991).
To test the idea that the plasma membrane and the ISD play
similar roles, we have combined an ISD deletion within M-
PMV Gag with two different modifications to direct Gag to the
plasma membrane. Use of the R55W mutation resulted in a
restitution of particle production in HeLa cells from 5% of the
wild-type level for the ISD-deleted form to 65% of that level
for the dual CTRS/DISD mutant. Directing the ISD-deleted
Gag to the plasma membrane restored its ability to assemble
efficiently as a C-type virus. In contrast to the results in HeLa
cells, in HOS cells the CTRS mutation itself was deleterious
and in combination with the ISD deletion was further impaired.
Since C-type assembling structures were observed in HOS cells
expressing the double mutant, we believe that this cell-type
dependent difference is due to variability in cellular transport
mechanisms rather than in the ability of ISD-deleted Gag to
utilize the plasma membrane.
To more directly examine the ability of the plasma
membrane targeting of Gag in HOS cells, we modified Gag
by substituting the entire MA domain with the membrane
targeting/myristylation sequence of src. The in vitro analysis
had already shown the MA domain to be dispensable for
assembly. Although all of the src sequence-directed Gags were
somewhat impaired versus the wild type, there was no
significant difference in particle production between the two
variants missing a functional ISD and the one that contained it.
In the context of forcing an interaction with the plasma
membrane, the presence of the ISD became irrelevant to
particle production, consistent with the hypothesis that the
plasma membrane can provide a scaffold-like function for the
many C-type Gag proteins that are targeted there.
How do the plasma membrane and the ISD both fulfill
similar functions? As discussed previously (Sakalian and
Hunter, 1999), these elements may serve to concentrate the
Gag polyprotein and thereby assist in the process of multi-
merization that leads to assembly. For both C-type and D-type
viruses, these scaffold-like functions are dispensable when Gag
is overexpressed in cells (Royer et al., 1991; Sakalian and
Hunter, 1999; Sommerfelt et al., 1992) or when Gag or Gag
fragments are purified and assembled at high concentration in
vitro (Campbell and Rein, 1999; Campbell and Vogt, 1997;
Gross et al., 2000; Klikova et al., 1995). For C-type viruses, the
plasma membrane may serve to concentrate Gag molecules by
simply restricting diffusion to two dimensions. For the D-type
virus, the mechanism of ISD function is unknown but may be
inferred from the behavior of the matured p12 domain that
contains it. p12 possesses an unusual propensity to multimerize
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soluble recombinant protein identified every possible multimer
of p12 on SDS-PAGE, from dimers to irresolvable multimers.
Much of this ability to self-associate was attributed to the N-
terminal helical portion of p12, which corresponds to the
location of ISD function characterized by deletion analysis
(Sakalian and Hunter, 1999; Sommerfelt et al., 1992).
In addition to Gag proteins that were targeted to the plasma
membrane, we found that a Gag deleted of all targeting signals,
Gag68, also efficiently assembled in cells, although these
assembled particles were not released. Several studies have
shown that the transport signals in MA can be altered without
abrogating assembly (Bowzard et al., 2000; Fa¨cke et al., 1993;
Ono et al., 2000). In fact, if the MA domain is replaced with a
minimal plasma membrane targeting signal, this region of Gag
is dispensable for particle production (Lee and Linial, 1994)
and indeed for infectivity (Reil et al., 1998). In addition, studies
of M-PMV Gag have shown that while the CA and NC
domains are necessary for assembly of particles, the MA
domain is not required when Gag is overexpressed in bacteria
(Rumlova-Klikova et al., 2000). It is likely that in the absence
of transport signals Gag68 simply accumulates at the site of
synthesis in the cell, and through the assistance of the ISD,
efficiently assembles into particles. The observation of large
accumulations of structures by this species is consistent with
this scenario.
All D-type viruses possess an ISD, but the other viruses in
the genus, at least by sequence analysis, do not appear to
contain an analogous leucine zipper-like region in their Gag
proteins. However, the mouse mammary tumor virus (MMTV),
the prototypical B-type retrovirus, does possess a Gag domain
p3 in the position analogous to p12 that contains a sequence of
similar charge composition. While the D-type virus contains
many glutamic acid residues in its leucine zipper-like region,
MMTV contains a similar number of aspartic acids (Moore et
al., 1987; Sonigo et al., 1986). Furthermore, in a two-hybrid
analysis of Gag–Gag interaction, p3, in combination with the
adjacent p8n domains, displayed a modest ability to self-
associate, as did the MA-pp21 and the CA regions—a property
not shared by the analogous regions of M-PMV (Za´bransky´ et
al., 2005). MMTV, therefore, appears to utilize the concerted
self-association of multiple Gag domains while M-PMV
utilizes the ISD.
If the plasma membrane can substitute for the function of
the ISD for a D-type virus, can the converse be true? Can an
ISD substitute for the function of the plasma membrane for a
C-type virus? Chimeric C-type Gag proteins containing an ISD
might assemble efficiently without the need for interaction with
the plasma membrane. When a CTRS was inserted into MA of
MuLV, D-type morphogenesis did result, but it was inefficient,
perhaps because of the absence of an ISD (Choi et al., 1999).
Fusing the p12 domain to the HIV Gag precursor enables
assembly of the chimera versus wild-type HIV Gag in the in
vitro translation system (Sakalian et al., 2002). This suggests
that the ISD is a modular domain of the polyprotein whose
function can be transferred to the Gag protein of another
retrovirus. Can adding a CTRS to such a chimeric Gag result inefficient D-type morphogenesis in cells? These experiments are
in progress.
Materials and methods
DNA constructs
Plasmids for expression in vitro were constructed in the
pTFCG.M100Avector background (Sakalian andHunter, 1999).
Plasmids pTFCG.R55W.M100A and pTFCG.M100A.D1–25
have already been described (Sakalian and Hunter, 1999).
Plasmid pTFCG.R55W.M100A.D1–25 was constructed by
transfer of the PacI to BsgI fragment of pTFCG.M100A.D1–
25, containing both the M100A and the D1–25 mutations, to
pTFCG.R55W.M100A. Plasmid pTFCG.Gag68 was con-
structed by site-directed mutagenesis of plasmid pTFCG to
convert the gag start codon from that for methionine (ATG) to
one for isoleucine (ATT). The result of this mutation is to
force translation of gag to begin at the second methionine
codon located at the end of the MA coding region yielding a
protein of approximately 68 kDa in size. Conversion of the
ATG to ATT had the added benefit of creating an additional
diagnostic SspI restriction site in the plasmid.
Plasmids for expression in tissue culture cells were con-
structed in the pSHRM15 vector background (Rhee et al., 1990).
Plasmids pSHRM15.M100A, pSHRM15.R55W.M100A,
pSHRM15.M100A.D1–25, and pSHRM15.R55W.M100A.D1–
25 were all constructed by transferring the PacI to BsgI frag-
ment from the corresponding pTFCG series plasmid into
pSHRM15. The src myristylation sequence-containing plasmids
pSHRM15.Gag68.(+)Myr, pSHRM15.Gag68.()Myr,
pSHRM15.Gag68.(+)Myr.D1–25, pSHRM15.Gag68.()Myr.D1–
25 pSHRM15.Gag68.(+)Myr.D8–58, and pSHRM15.
Gag68.()Myr.D8–58 were constructed in the pSHRM15.
Gag68 and pSHRM15.Gag68.D1–25 vector backgrounds.
First, the DraIII to SpeI fragment of pTFCG.68 was
transferred to pBluescript-KSII to produce the 3.2 kb plasmid
nr-ksvector-1. Primer pairs were designed for insertion of the
src sequence into nr-ksvector-1 just upstream of the pp24
coding sequence (Forward- 5V GTT AAC CCA CAA GTA
ATG GGG AGC AGC AAG AGC AAG CCT AAG GAC
GCT GCC GTA GCC C 3V; Reverse- 5V G GGC TAC GGC
AGC GTC CTT AGG CTT GCT CTT GCT GCT CCC 3V).
For addition of the src sequence without myristylation, similar
primer pairs were designed with the initial src glycine codon
changed to an alanine (Forward- 5V GTT AAC CCA CAA
GTA ATG GCC AGC AGC AAG AGC AAG CCT AAG
GAC GCT GCC GTA GCC C 3V; Reverse- 5V G GGC TAC
GGC AGC GTC CTT AGG CTT GCT CTT GCT GCT GGC
CAT TAC TTG TGG GTT AAC 3V). Additional outside
primers were designed for the PCR reactions (Forward-5V
GGG TAA AAA ACG TCT AGG CCC CCC G 3V; Reverse-5V
TAC GCA AAC CGC CTC TCC CCG CGC G 3V) for use in
combination with the mutagenic primers. PCR was performed
by first using pairs of primers (forward mutagenic with outside
reverse, reverse mutagenic with outside forward) to produce
intermediate products that were purified and then combined in
M. Sakalian, N.D. Rapp / Virology 345 (2006) 317–327 325a second PCR reaction with the outside primer pair to produce
a larger fragment containing the mutated sequence. This final
PCR product was then cloned into plasmid pCR2.1 (Invitro-
gen) using the manufacturer’s instructions. These intermediate
clones were confirmed by sequencing. Fragments including
the (+) and () myristylation src sequences were then excised
from the pCR2.1 vector by digestion with PacI and SpeI and
inserted into the similarly digested pTFCG.Bam(), a BamHI
to BamHI-deleted version of pTFCG. The PacI to SacI
fragment from the resulting (+) and () version plasmids was
then inserted into the same sites of pSHRM15.Gag68 and
pSHRM15.Gag68.D1–25.
In vitro analysis of immature capsid assembly
Transcription and translation were performed simultaneous-
ly using the TNT Coupled Reticulocyte Lysate System
(Promega) in the presence of [35S]-methionine and
programmed with the pTFCG series plasmids. Products of
these synthesis reactions were analyzed on sucrose gradients.
Standard 50 Al reactions were diluted to a total volume of 200
Al with 30% (w/w) sucrose in gradient buffer containing 20
mM Tris (pH 8.0), 100 mM NaCl, 5 mM EDTA, and 0.1%
Triton X-100. Diluted samples were then loaded onto 2.2-ml
continuous 30–55% (w/w) sucrose gradients. Gradients were
centrifuged in a TLS-55 rotor (Beckman Instruments) for 2 h at
55,000 rpm. Approximately 200-Al fractions were taken by
hand with a Pipetman (Gilson) from the top of the gradient.
The pellet was resuspended in 200 Al of 55% (w/w) sucrose in
gradient buffer. Aliquots (5 Al) of each fraction were dissolved
in sodium dodecyl sulfate (SDS) sample buffer and then loaded
onto an SDS-10% polyacrylamide gel. After electrophoresis,
radioactive bands were visualized on a Packard Cyclone
Storage Phosphor Screen system.
Pulse-chase analysis of particle production in cultured cells
Tissue culture cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum, 20 mM l-glutamine, 100 U/ml of penicillin G and 100
Ag/ml streptomycin sulfate. Both HeLa and HOS cells were
transfected with FuGENE 6 (Roche) reagent according to the
manufacturer’s instructions. Before transfection, pSHRM15
series plasmids were linearized by digestion with FspI. Stable
cell lines were batch selected and maintained in the presence of
300 U/ml of Hygromycin B.
Cell lines and control cells were pulse labeled in DMEM
minus methionine (Specialty Media) supplemented with 50
ACi/ml of [35S]-methionine. The label was chased overnight by
replacing the labeling medium with maintenance medium. For
analysis of intracellular Gag species, labeled cells were lysed in
buffer containing 0.15 M NaCl, 50 mM Tris–HCl (pH 7.5), 1%
Triton X-100, and 1% deoxycholate (Lysis Buffer). Cellular
debris and nuclei were removed by centrifugation for 1 min at
14,000 rpm in an Eppendorf microfuge (Brinkmann Instru-
ments). The lysate was then adjusted to 0.1% SDS and the M-
PMV Gag species were precipitated by the addition ofpolyclonal anti-Pr78 antiserum (Sakalian et al., 1996) followed
by formalin-fixed Staph. aureus. For analysis of released virus
particles, tissue culture medium was first filtered through a 0.45
Am filter. Particles were then collected by centrifugation
through a 20% w/v sucrose cushion at 30,000 rpm for 90
min in a 70.1 Ti rotor (Beckman-Coulter). Pelleted virions were
dissolved in Lysis Buffer plus 0.1% SDS and the Gag species
immunoprecipitated as for cell lysates. Immunoprecipitates
were examined by separation on SDS-10% PAGE gels
followed by phosphorimager analysis.
Electron microscopy
For analysis of tissue culture cells, the medium was
removed and the plates washed 3 in phosphate buffered
saline. Cells were then fixed on the plate for 1 h with a solution
of 0.1 M cacodylate (pH 7.4) buffer containing 3% electron
microscopy grade (EM grade) glutaraldehyde and 0.8% tannic
acid. After three rinses in cacodylate buffer, the cells were
postfixed, in the dark, in 0.1 M cacodylate buffer containing
0.1% osmium tetroxide. The samples were again rinsed three
times and then dehydrated in a series of 50, 75, 95, and finally
100% ethanol (EM grade) solutions for 5 min each. The 100%
ethanol step was repeated two times and the samples were then
infiltrated in a 1:1 solution of Polybed 812 resin and 100%
ethanol overnight followed by three infiltrations with 100%
Polybed resin for 2 h. Embedding was performed overnight in
a thin layer of 100% Polybed at 60 -C. The embedded cell
layer was pried off the plate and then a small piece was
punched out, which was then glued to a prepolymerized block
of resin. Ultrathin sections were acquired by using a Rechert-
Jung Ultra Cut E ultramicrotome. Sections were poststained for
10 min in a solution of 1% uranyl acetate in 50% ethanol,
washed in ¨35 -C water, further stained for 5 min in Reynold’s
lead citrate, and then finally washed again in water. Sections
were examined and photographed by using a Hitachi-7000
transmission electron microscope at 75 kV.
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